{"id":64863,"date":"2024-11-02T12:47:51","date_gmt":"2024-11-02T12:47:51","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=64863"},"modified":"2026-04-30T10:23:28","modified_gmt":"2026-04-30T10:23:28","slug":"xtane","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/xtane\/","title":{"rendered":"Xtane"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 R\u0103spuns rapid \u2014 Ce este Xtane?<\/h3>\n<p style=\"margin:0;\"><strong>Xtane<\/strong> este un comprimat oral de la Natco Pharma care con\u021bine <strong>exemestane 25 mg<\/strong> \u2014 un inhibitor steroidal de aromataz\u0103 de genera\u021bia a treia <strong>inactivator steroidal al aromatazei<\/strong>. Terapie adjuvant\u0103 \u0219i metastatic\u0103 pentru <strong>cancerul mamar cu receptori hormonali pozitivi la femeile postmenopauzale<\/strong>. Doz\u0103 standard: <strong>25 mg o dat\u0103 pe zi dup\u0103 mas\u0103<\/strong>, de obicei pentru <strong>5\u201310 ani<\/strong> \u00een regim adjuvant. Exemestane inactiv\u0103 ireversibil aromataza (inhibitor sinucidere) fa\u021b\u0103 de legarea reversibil\u0103 a anastrozolului\/letrozolului. Adesea AI de alegere pentru terapia secven\u021bial\u0103 dup\u0103 2\u20133 ani de <a href=\"https:\/\/medsbase.com\/ro\/tamilong\/\">tamoxifen<\/a> (conform studiului IES), sau dup\u0103 intoleran\u021b\u0103 la un AI non-steroidal. <strong>Doar pentru femei postmenopauzale.<\/strong> Acelea\u0219i probleme de densitate osoas\u0103 \u0219i artralgie ca la celelalte AI \u2014 monitorizare obligatorie DEXA + calciu\/vitamin\u0103 D + se poate lua \u00een considerare un bifosfonat.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:0 0 24px 0;border-radius:4px;font-size:14px;\"><strong>\u26a0 Supraveghere specializat\u0103 necesar\u0103.<\/strong> Medicamentele pentru cancer trebuie prescrise de un oncolog tratant, cu un diagnostic confirmat, stadializare ini\u021bial\u0103 \u0219i un plan de tratament definit. Nu \u00eencepe\u021bi, nu opri\u021bi, nu modifica\u021bi doza \u0219i nu utiliza\u021bi medicamente pentru cancer \u00een afara unui plan de \u00eengrijire condus de oncologie. Majoritatea medicamentelor pentru cancer necesit\u0103 monitorizare regulat\u0103 prin analize de s\u00e2nge (hemoleucogram\u0103, teste hepatice, func\u021bie renal\u0103), sunt absolut contraindicate \u00een sarcin\u0103 \u0219i au interac\u021biuni medicamentoase semnificative.<\/div>\n<div style=\"background:#f4f8fb;border:1px solid #d6e4ec;padding:12px 18px;margin:14px 0;border-radius:4px;font-size:14px;color:#3a5160;text-align:center;\">\n<strong>\ud83d\udd12 Checkout criptat<\/strong> \u00b7 <strong>\ud83d\udcb3 Procesor verificat<\/strong> \u00b7 <strong>\ud83d\ude9a Livrare worldwide<\/strong> \u00b7 <strong>\u2b50 4,9\/5 de la peste 1.400 de clien\u021bi<\/strong>\n<\/div>\n<h2 class=\"wp-block-heading\">Ce este Xtane?<\/h2>\n<p>Xtane este un comprimat oral de la Natco Pharma care con\u021bine <strong>exemestane 25 mg<\/strong>. Exemestane este un inhibitor de aromata\u021b\u0103 de genera\u021bia a treia, <strong>steroidal<\/strong> \u2014 distinct structural \u0219i mecanistic de inhibitorii non-steroidici ai aromatazei anastrozol \u0219i letrozol. Este utilizat \u00een tratamentul adjuvant \u0219i metastatic al cancerului de s\u00e2n cu receptori hormonali pozitivi (HR+) la <strong>femei postmenopauzale<\/strong>. Dezvoltat ini\u021bial de Pfizer (sub denumirea comercial\u0103 Aromasin), exemestane este acum un medicament generic utilizat pe scar\u0103 larg\u0103.<\/p>\n<h2 class=\"wp-block-heading\">Cum func\u021bioneaz\u0103 Xtane?<\/h2>\n<p>Exemestane este un <strong>inhibitor cu substrat sinucidere<\/strong> (inactivator ireversibil) al aromatazei, enzima care transform\u0103 androgenii \u00een estrogeni \u00een \u021besuturile periferice postmenopauzale. Din punct de vedere mecanic:<\/p>\n<ul>\n<li><strong>Structur\u0103 steroidal\u0103<\/strong> asem\u0103n\u00e2ndu-se cu substratul androgen natural (androstenedion\u0103) \u2014 se leag\u0103 de situsul activ al aromatazei \u0219i este apoi convertit ireversibil \u00eentr-un aduct covalent al enzimei care inactivateaz\u0103 permanent molecula enzimatic\u0103.<\/li>\n<li><strong>Suprim\u0103 estrogenul circulant cu ~95%<\/strong> \u00een c\u00e2teva zile \u2014 comparabil cu anastrozol \u0219i letrozol.<\/li>\n<li><strong>F\u0103r\u0103 rezisten\u021b\u0103 \u00eencruci\u0219at\u0103 cu inhibitorii non-steroidieni ai aromatozei<\/strong> \u2014 pacien\u021bii care au progresat pe anastrozol sau letrozol r\u0103spund uneori la exemestan (\u0219i vice-versa) deoarece mecanismul este structural distinct.<\/li>\n<li><strong>Efect androgen slab<\/strong> \u2014 exemestanul \u0219i metabolitul s\u0103u principal au o activitate slab\u0103 la nivelul receptorului de androgen, ceea ce poate atenua u\u0219or pierderea densit\u0103\u021bii osoase observat\u0103 cu inhibitorii non-steroidieni de aromataz\u0103 (de\u0219i semnifica\u021bia clinic\u0103 este dezb\u0103tut\u0103).<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Utiliz\u0103ri \u0219i indica\u021bii<\/h2>\n<ul>\n<li><strong>Terapie adjuvant\u0103<\/strong> pentru cancerul mamar HR+ \u00een stadiu incipient la femei postmenopauzale, de obicei ca terapie secven\u021bial\u0103 dup\u0103 2\u20133 ani de <a href=\"https:\/\/medsbase.com\/ro\/tamilong\/\">tamoxifen<\/a> (conform studiului IES) sau ca AI principal<\/li>\n<li><strong>Cancer mamar HR+ metastatic<\/strong> dup\u0103 progresie pe un inhibitor non-steroidian de aromataz\u0103 (anastrozol sau letrozol)<\/li>\n<li><strong>Combinat cu everolimus<\/strong> pentru cancerul mamar HR+ HER2- metastatic dup\u0103 e\u0219ecul inhibitorilor non-steroidieni de aromataz\u0103 (BOLERO-2)<\/li>\n<li><strong>Off-label:<\/strong> chimiopreven\u021bie la femeile postmenopauzale cu risc ridicat (studiu MAP.3); inducerea ovula\u021biei \u00een PCOS (specialist)<\/li>\n<\/ul>\n<p>Xtane este <strong>prime\u0219te,<\/strong> indicat pentru: femei premenopauzale f\u0103r\u0103 suprimare ovarian\u0103, cancer de s\u00e2n HR-negativ sau indica\u021bii cosmetice non-canceroase.<\/p>\n<h2 class=\"wp-block-heading\">Doza Xtane \u0219i cum s\u0103 o lua\u021bi<\/h2>\n<p>Doza standard: <strong>25 mg o dat\u0103 pe zi dup\u0103 mas\u0103<\/strong>. Alimentele cresc biodisponibilitatea exemestanului cu aproximativ 40% \u2014 deci aceasta este mai mult dec\u00e2t o simpl\u0103 regul\u0103 de tolerabilitate.<\/p>\n<h3 class=\"wp-block-heading\">Cum s\u0103 lua\u021bi Xtane corect<\/h3>\n<ol>\n<li><strong>Lua\u021bi o tablet\u0103 de 25 mg o dat\u0103 pe zi dup\u0103 o mas\u0103.<\/strong> Alimentele cresc semnificativ absorb\u021bia \u2014 NU lua\u021bi pe stomacul gol.<\/li>\n<li><strong>La aceea\u0219i or\u0103 \u00een fiecare zi<\/strong> pentru consisten\u021b\u0103.<\/li>\n<li><strong>\u00cenghi\u021bi\u021bi \u00eentreaga tablet\u0103 cu ap\u0103.<\/strong><\/li>\n<li><strong>Monitorizare obligatorie:<\/strong> scanare DEXA de baz\u0103 a densit\u0103\u021bii osoase, repetat\u0103 la fiecare 2 ani. Panel lipidic anual.<\/li>\n<li><strong>Protec\u021bie osoas\u0103:<\/strong> calciu 1.000\u20131.200 mg\/zi + vitamina D 800\u20132.000 UI\/zi. Bifosfonat sau denosumab dac\u0103 apare osteopenie.<\/li>\n<li><strong>Managementul durerii articulare:<\/strong> exerci\u021biu regulat, paracetamol\/NSAID-uri dup\u0103 necesitate. Trecerea la <a href=\"https:\/\/medsbase.com\/ro\/anaridex\/\">anastrozol<\/a> sau <a href=\"https:\/\/medsbase.com\/ro\/letroheal\/\">letrozol<\/a> poate ajuta dac\u0103 artralgia cauzat\u0103 de exemestan este intolerabil\u0103.<\/li>\n<li><strong>Durata cursului:<\/strong> 5 ani de terapie endocrin\u0103 total\u0103 (sau mai mult \u00een cazuri cu risc crescut) \u00een regim adjuvant; p\u00e2n\u0103 la progresie \u00een stadiu metastatic.<\/li>\n<li><strong>Nu \u00eentrerupe\u021bi f\u0103r\u0103 instruc\u021biuni de la oncolog.<\/strong><\/li>\n<\/ol>\n<h2 class=\"wp-block-heading\">Efecte Secundare ale Xtane<\/h2>\n<p><strong>Comune (simptome de deprivare estrogenic\u0103):<\/strong><\/p>\n<ul>\n<li>V\u0103rs\u0103turi de c\u0103ldur\u0103 (35\u201340%)<\/li>\n<li>Artralgie \u0219i mialgie (~30%)<\/li>\n<li>Usc\u0103ciune vaginal\u0103, dispareunie<\/li>\n<li>Schimb\u0103ri de dispozi\u021bie, oboseal\u0103<\/li>\n<li>Sub\u021biere u\u0219oar\u0103 a p\u0103rului<\/li>\n<li>Transpira\u021bie crescut\u0103<\/li>\n<li>Grea\u021b\u0103 (u\u0219oar\u0103, de obicei trece)<\/li>\n<\/ul>\n<p><strong>Important pe termen lung:<\/strong><\/p>\n<ul>\n<li>Pierdere accelerat\u0103 a densit\u0103\u021bii osoase \u0219i risc crescut de fractur\u0103 \u2014 posibil u\u0219or mai mic dec\u00e2t la AI-uri non-steroidiene (efect androgen u\u0219or al exemestanului), dar semnifica\u021bia clinic\u0103 este dezb\u0103tut\u0103<\/li>\n<li>Efecte secundare androgenice u\u0219oare (acnee, modific\u0103ri ale p\u0103rului) \u2014 neobi\u0219nuite, dar distinctive<\/li>\n<li>Hiperlipidemie (u\u0219oar\u0103)<\/li>\n<\/ul>\n<p><strong>Mai pu\u021bin frecvente, dar necesit\u0103 evaluare:<\/strong><\/p>\n<ul>\n<li>Hepatotoxicitate (cre\u0219teri minore ale enzimelor hepatice frecvente)<\/li>\n<li>Limbocitopenie, trombocitopenie<\/li>\n<li>Hipersensibilitate sever\u0103<\/li>\n<li>Sindromul tunelului carpian<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Avertismente \u0219i precau\u021bii<\/h2>\n<ul>\n<li><strong>Sarcina: CONTRAINDICA\u021aIE ABSOLUT\u0102.<\/strong> Exemestanul este teratogen. Pacientele postmenopauzale sunt de obicei dincolo de v\u00e2rsta fertil\u0103, dar pacientele perimenopauzale necesit\u0103 contracep\u021bie fiabil\u0103.<\/li>\n<li><strong>Femei premenopauzale:<\/strong> ineficace dec\u00e2t dac\u0103 este combinat cu suprima\u021bie ovarian\u0103 sub \u00eendrumare specializat\u0103.<\/li>\n<li><strong>S\u0103n\u0103tatea osoas\u0103:<\/strong> DEXA de baz\u0103, repetat la fiecare 2 ani. Calciu + vitamina D + bisfosfonat\/denosumab \u00een caz de osteopenie.<\/li>\n<li><strong>Insuficien\u021b\u0103 hepatic\u0103 \u0219i renal\u0103:<\/strong> nu este necesar\u0103 ajustarea dozei pentru afec\u021biuni u\u0219oare p\u00e2n\u0103 la moderate; se recomand\u0103 precau\u021bie \u00een cazul afec\u021biunilor severe.<\/li>\n<li><strong>Terapie estrogenic\u0103 concomitent\u0103:<\/strong> evita\u021bi \u2014 contravine scopului.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Interac\u021biuni medicamentoase<\/h2>\n<table style=\"border-collapse:collapse;width:100%;margin:12px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Combina\u021bi cu<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Efect<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Ce s\u0103 face\u021bi<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Inductori puternici ai CYP3A4 (rifampicin\u0103, fenitoin\u0103, carbamazepin\u0103, Hypericum perforatum)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Niveluri sc\u0103zute de exemestan \u2014 risc de e\u0219ec terapeutic<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Evita\u021bi combina\u021bia. Dac\u0103 inductorul CYP3A4 este esen\u021bial, dubla\u021bi doza de exemestan la 50 mg\/zi sub \u00eendrumare specializat\u0103.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">THS cu estrogen sau estrogen vaginal<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Contravine mecanismului \u2014 tratamentul e\u0219ueaz\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Evita\u021bi. Utiliza\u021bi emoliente vaginale nehormonale.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Tamoxifen<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Tamoxifenul reduce nivelurile de exemestan<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Utiliza\u021bi secven\u021bial, nu concomitent.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Bifosfona\u021bi \/ denosumab<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Protec\u021bie osoas\u0103 sinergic\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Ad\u0103uga\u021bi c\u00e2nd apare osteopenie.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Everolimus (inhibitor mTOR<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Combina\u021bie standard pentru cancerul de s\u00e2n metastatic HR+ HER2- (BOLERO-2)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Prescriere oncologic\u0103 specializat\u0103.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 class=\"wp-block-heading\">Instruc\u021biuni de Depozitare<\/h2>\n<ul>\n<li>Se p\u0103streaz\u0103 la temperatura camerei, <strong>15\u201330\u00b0C<\/strong>. P\u0103stra\u021bi \u00een blisterul original.<\/li>\n<li>P\u0103stra\u021bi departe de copii \u0219i animale de companie.<\/li>\n<li>Returna\u021bi comprimatele nefolosite la o farmacie pentru eliminare.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Alternative conexe pe MedsBase<\/h2>\n<p>Alte medicamente oncologice disponibile \u00eempreun\u0103 cu acest produs:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/anaridex\/\"><strong>Anaridex (anastrozol 1 mg)<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/fempro\/\"><strong>Fempro (letrozol 2.5 mg)<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/letroheal\/\"><strong>Letroheal (letrozol 2,5 mg)<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/tamilong\/\"><strong>Tamilong (tamoxifen 10 \/ 20 mg)<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/tamodex\/\"><strong>Tamodex (tamoxifen 10 \/ 20 mg)<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/tamoxilon\/\"><strong>Tamoxilon (tamoxifen 10 \/ 20 mg)<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/cytotam\/\"><strong>Cytotam (tamoxifen 10 \/ 20 mg)<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/caditam\/\"><strong>Caditam (tamoxifen 20 mg)<\/strong><\/a><\/li>\n<\/ul>\n<p><a href=\"https:\/\/medsbase.com\/ro\/anti-cancer-medication\/\">R\u0103sfoi\u021bi toate medicamentele anti-cancer \u2192<\/a><\/p>\n<p><!-- medsbase-why-order --><\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Fiecare lot este procurat de la un <strong>produc\u0103tor certificat WHO-GMP<\/strong>. Comenzile sunt expediate \u00een ambalaje simple, f\u0103r\u0103 marc\u0103, de la partenerii no\u0219tri de onorare \u0219i acoperite de <a href=\"\/ro\/medsbase-re-shipment-assurance-policy\/\">Politica noastr\u0103 de Reexpediere Garantat\u0103<\/a>: dac\u0103 un colet nu ajunge \u00een 20 de zile lucr\u0103toare, trimitem gratuit o nou\u0103 comand\u0103, f\u0103r\u0103 \u00eentreb\u0103ri.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Medicamente Anticanceroase Asem\u0103n\u0103toare<\/h3>\n<p>Alte medicamente oncologice disponibile \u00eempreun\u0103 cu acest produs:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/anaridex\/\">Anaridex (anastrozol 1 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/letroheal\/\">Letroheal (letrozol 2,5 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/fempro\/\">Fempro (letrozol 2.5 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/tamilong\/\">Tamilong (tamoxifen 10\/20 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/tamodex\/\">Tamodex (tamoxifen 10\/20 mg)<\/a><\/li>\n<\/ul>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3 class=\"wp-block-heading\">De ce trebuie Xtane luat cu m\u00e2ncare?<\/h3>\n<p>M\u00e2ncarea cre\u0219te biodisponibilitatea exemestanului cu aproximativ <strong>40%<\/strong> \u2014 acesta este un efect farmacocinetic real, nu doar o regul\u0103 de tolerabilitate. Administrarea exemestanului pe stomac gol subdozeaz\u0103 semnificativ. Lua\u021bi dup\u0103 prima mas\u0103 principal\u0103 a zilei pentru absorb\u021bie consistent\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Cum difer\u0103 Xtane de anastrozol \u0219i letrozol?<\/h3>\n<p>Exemestane este un <strong>steroidal<\/strong> inactivator de aromataz\u0103 care distruge ireversibil moleculele enzimei aromatazei. Anastrozolul \u0219i letrozolul sunt <strong>inhibitori nesteroizi<\/strong> reversibili. Implica\u021biile clinice: (1) nicio rezisten\u021b\u0103 \u00eencruci\u0219at\u0103 \u2014 pacien\u021bii care progreseaz\u0103 pe anastrozol sau letrozol pot \u00eenc\u0103 r\u0103spunde la exemestan; (2) efect androgen u\u0219or al exemestanului (uneori folosit pentru a argumenta o pierdere osoas\u0103 marginal mai mic\u0103, de\u0219i semnifica\u021bia clinic\u0103 este dezb\u0103tut\u0103); (3) efect diferit al alimentelor (absorb\u021bia exemestanului cre\u0219te cu 40% cu m\u00e2ncare).<\/p>\n<h3 class=\"wp-block-heading\">C\u00e2nd este preferat Xtane \u00een loc de anastrozol sau letrozol?<\/h3>\n<p>Trei scenarii comune: (1) terapie secven\u021bial\u0103 dup\u0103 2\u20133 ani de tamoxifen (studiu IES a folosit exemestan \u00een acest context); (2) dup\u0103 progresare pe anastrozol sau letrozol \u2014 mecanismul structural distinct poate oferi un r\u0103spuns re\u00eennoit; (3) dup\u0103 artralgie intolerabil\u0103 la un AI nesteroid \u2014 aproximativ 30% dintre pacien\u021bi tolereaz\u0103 un AI dar nu altul.<\/p>\n<h3 class=\"wp-block-heading\">C\u00e2t timp trebuie s\u0103 iau Xtane?<\/h3>\n<p>Durata standard adjuvant\u0103 este <strong>5 ani<\/strong> terapia endocrin\u0103 total\u0103 (aceasta poate include tamoxifen sau un alt AI \u00een primii 2\u20133 ani dac\u0103 exemestanul este utilizat \u00een regim secven\u021bial). Pentru boala cu risc crescut cu afectare ganglionar\u0103, terapia extins\u0103 p\u00e2n\u0103 la <strong>7\u201310 ani<\/strong> este din ce \u00een ce mai utilizat\u0103. Pentru boala metastatic\u0103, p\u00e2n\u0103 la progresie sau toxicitate intolerabil\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Xtane va sl\u0103bi oasele mele?<\/h3>\n<p>Da \u2014 ca to\u021bi inhibitorii de aromataz\u0103. Unele date sugereaz\u0103 c\u0103 exemestanul poate produce o pierdere osoas\u0103 u\u0219or mai mic\u0103 dec\u00e2t anastrozolul sau letrozolul datorit\u0103 efectului s\u0103u androgen u\u0219or, dar semnifica\u021bia clinic\u0103 este dezb\u0103tut\u0103 \u0219i presupunerea sigur\u0103 este c\u0103 este necesar\u0103 protec\u021bia osoas\u0103. DEXA de baz\u0103 obligatorie, repetat la fiecare 2 ani. Suplimentare cu calciu + vitamina D. Bifosfonat (acid zoledronic IV la fiecare 6 luni) sau denosumab (60 mg SC la fiecare 6 luni) dac\u0103 exist\u0103 osteopenie.<\/p>\n<h3 class=\"wp-block-heading\">Cum pot gestiona durerea articular\u0103 la Xtane?<\/h3>\n<p>Aceea\u0219i abordare ca \u0219i pentru alte AI: exerci\u021bii regulate (yoga, mers pe jos, \u00eenot), suplimentare cu vitamina D, paracetamol sau cursuri scurte de NSAID, gestionarea greut\u0103\u021bii. Dac\u0103 este intolerabil, trecerea la <a href=\"https:\/\/medsbase.com\/ro\/anaridex\/\">anastrozol<\/a> sau <a href=\"https:\/\/medsbase.com\/ro\/letroheal\/\">letrozol<\/a> uneori ajut\u0103. Acupunctura are dovezi modeste \u00een artralgia indus\u0103 de AI.<\/p>\n<h3 class=\"wp-block-heading\">Pot folosi THS sau estrogen vaginal la Xtane?<\/h3>\n<p>\u00cen general nu \u2014 chiar \u0219i doze mici de estrogen vaginal produc absorb\u021bie sistemic\u0103 m\u0103surabil\u0103 care poate anula terapia cu AI. Prima linie pentru simptome vaginale: emolien\u021bi non-hormonali (Replens, geluri cu acid hialuronic) \u0219i lubrifian\u021bi pe baz\u0103 de ap\u0103. Speciali\u0219tii iau ocazional \u00een considerare estrogen vaginal \u00een doze foarte mici pe baz\u0103 individual\u0103 de risc-beneficiu.<\/p>\n<h3 class=\"wp-block-heading\">Exist\u0103 interac\u021biuni medicamentoase de care trebuie s\u0103 m\u0103 \u00eengrijorez?<\/h3>\n<p>Cea principal\u0103 este <strong>induc\u0103torii puternici de CYP3A4<\/strong> (rifampicin\u0103, fenitoin\u0103, carbamazepin\u0103, iarba Sf\u00e2ntului Ioan) care reduc semnificativ nivelurile de exemestan. Dac\u0103 un inductor CYP3A4 este esen\u021bial, doza poate fi dublat\u0103 la 50 mg\/zi sub \u00eendrumare specializat\u0103. Evita\u021bi complet iarba Sf\u00e2ntului Ioan. Altfel, exemestanul are relativ pu\u021bine interac\u021biuni medicamentoase.<\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Reduce nivelul de estrogen<br \/>\n\u2705 Reduce cre\u0219terea cancerului<br \/>\n\u2705 Sus\u021bine s\u0103n\u0103tatea s\u00e2nului<br \/>\n\u2705 Eficace postoperator<br \/>\n\u2705 Reduce riscul de recidiv\u0103<\/p>\n<p>Xtane con\u021bine <strong>Exemestan<\/strong>.<\/p>","protected":false},"featured_media":64866,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[3595],"product_tag":[5326,5325],"class_list":{"0":"post-64863","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-anti-cancer-medication","7":"product_tag-exemestane","8":"product_tag-xtane","10":"first","11":"instock","12":"shipping-taxable","13":"purchasable","14":"product-type-variable","15":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/64863","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=64863"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/64866"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=64863"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=64863"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=64863"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=64863"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}